Parallax Volatility Advisers’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-200
Closed -$9K 3168
2021
Q2
$9K Buy
+200
New +$8.85K ﹤0.01% 2778
2018
Q2
Sell
-8,500
Closed -$167K 2589
2018
Q1
$167K Buy
+8,500
New +$165K ﹤0.01% 1281
2017
Q2
Sell
-100,000
Closed -$1.3M 2939
2017
Q1
$1.3M Buy
+100,000
New +$1.26M ﹤0.01% 1038

Other funds holding HALO

Parallax Volatility Advisers's HALO Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Halozyme (HALO) in Q3 2021, closing a stake of 66 shares — an estimated $3K sold.

Parallax Volatility Advisers first reported a position in HALO in Q1 2017 and held it in 4 quarters. The position peaked at $370K in Q4 2017. 325 funds tracked by Wall St. Rank hold HALO as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining Halozyme position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 66 Halozyme shares in Q3 2021, an estimated $3K.
  • Parallax Volatility Advisers first reported a position in Halozyme in Q1 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's Halozyme position peaked at $370K in Q4 2017.
  • 325 funds tracked by Wall St. Rank held Halozyme as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.